News - Pricing

Filter

Current filters:

Pricing

Popular Filters

140 to 164 of 677 results

Stability in the Australia's PBS relies on increased use of generic medicines

29-08-2013

Australia's Generic Medicines Industry Association (GMiA) welcomes the Health Debate at the National…

Asia-PacificFinancialGenericsHealthcarePricing

Japan's PM supports reform of drug pricing rules

27-08-2013

The Japanese Prime Minister, Shinzo Abe, last week held a meeting of the Council for Regulatory Reform…

Asia-PacificPharmaceuticalPoliticsPricing

Aid group urges countries not to trade away health as TPP negotiations intensify

23-08-2013

The far-reaching Trans-Pacific Partnership Agreement (TPP) should be a force for improving health outcomes…

GenericsGlobalPatentsPharmaceuticalPricing

Drug swap drives down costs for US Medicare

23-08-2013

Therapeutic drug substitutions have the potential to double or even triple annual cost savings compared…

FinancialGenericsHealthcareNorth AmericaPricing

Support for the Australia's PBS from Coalition Senators

22-08-2013

Ahead of the September 7 elections, Australian Coalition Senators have issued a statement acknowledging…

Asia-PacificPharmaceuticalPoliticsPricingRegulation

New Zealand proposals for influenza vaccines

21-08-2013

New Zealand's Pharmaceutical Management Agency PHARMAC is seeking feedback on a proposal to list two…

Abbott LaboratoriesAsia-PacificFluarixGlaxoSmithKlineInfluvacPharmaceuticalPricingRegulationVaccines

Japan's MHLW approves 367 generics, but what does this mean?

21-08-2013

Japan's Ministry of Health Labor and Welfare (MHLW) approved 367 items of generic drugs last week. Launch…

Asia-PacificDiovanGenericsNovartisPharmaceuticalPricingRegulation

NICE says Xalkori is not cost effective in ALK-positive NSCLC

20-08-2013

US pharma behemoth Pfizer (NYSE: PFE) has today (August 16) expressed concern and disappointment that…

EuropeOncologyPfizerPharmaceuticalPricingRegulationXalkori

BIA warns that UK government pricing proposals would damage UK biotech

20-08-2013

The BioIndustry Association (BIA), the UK trade association for the innovative biotechnology sector,…

AvastinBayerEuropeEyleaFinancialLucentisPharmaceuticalPoliticsPricingRegeneronRoche

Pharma companies allow drug brand's attributes to guide pricing

14-08-2013

From pharmacists to doctors to patients, many different groups - along with general market forces at…

PharmaceuticalPricing

In wake of Tivicay approval, MSF asks, "when will people in developing countries have access?"

13-08-2013

As the US Food and Drug Administration approved the new HIV drug Tivicay (dolutegravir) late Monday (The…

Anti-viralsdolutegravirGlobalHealthcarePharmaceuticalPricingTivicayViiV Healthcare

Australian Pharmacy Guild takes its case to the public

12-08-2013

Pharmacy patients around Australia are being urged to rally against a shock federal government decision…

Asia-PacificFinancialGenericsPricing

China starts investigation of alleged bribery by Sanofi

12-08-2013

Following last week's whistleblower allegations that French drug major Sanofi (Euronext: SAN) had paid…

Asia-PacificLegalMarkets & MarketingPharmaceuticalPricingSanofi

Mitsubishi Tanabe succeeds in arbitration

11-08-2013

Japanese drug major Mitsubishi Tanabe Pharma (TYO: 4508) says it has been awarded $117 million in an…

Anti-Arthritics/RheumaticsAsia-PacificJanssen BiotechJohnson & JohnsonLicensingMitsubishi TanabePharmaceuticalPricingRemicade

Czech drugmakers hampered in bringing modern pharmaceuticals to the market

11-08-2013

Members of the Association of Innovative Pharmaceutical Industry (AIFP) and the Czech Association of…

EuropePharmaceuticalPoliticsPricing

IQWiG finds no added benefit proven for Constella in IBS

07-08-2013

In an early benefit assessment under the German Act on the Reform of the Market for Medicinal Products…

AlmirallConstellaEuropeGastro-intestinalsIronwood PharmaceuticalsPharmaceuticalPricingRegulation

UK NICE guidance says breast cancer drug Perjeta not value for money

06-08-2013

The UK's National Health Service (NHS) is to be advised that it should not routinely provide Swiss drug…

BiotechnologyEuropeOncologyPerjetaPharmaceuticalPricingRegulationRoche

Roche strikes deal with Medicines Patent Pool on medicines access

05-08-2013

Swiss drug major Roche (ROG: SIX) has entered into an agreement with the Medicines Patent Pool, a Geneva,…

Anti-viralsMarkets & MarketingPharmaceuticalPricingRocheValcyte

Australia's price disclosure change to put even more pressure on pharmacies, says Pharmacy Guild

05-08-2013

The Australian government last week announced plans that would save patient hundreds of dollars a year…

Asia-PacificFinancialPharmaceuticalPricing

Japanese government committee has kicked off reform on drug pricing system

05-08-2013

Revision of drug pricing rules in Japan gained momentum when the Council of Regulatory Reforms (CRR)…

Asia-PacificGenericsPharmaceuticalPricing

Germany's IQWiG confirms Jetrea's added value for VMT patients

02-08-2013

Belgian biopharma company ThromboGenics (Euronext Brussels: THR) announced today (August 2) that the…

BiotechnologyEuropeJetreaOphthalmicsPharmaceuticalPricingRegulationThromboGenics

Spanish generic drug market grows more slowly and small companies start suffering

31-07-2013

The Spanish generic drugs industry is going through a complex stage. The latest example is the decision…

EuropeGenericsMarkets & MarketingPricing

GAVI Alliance gets reduced price offers from Pfizer and GSK

30-07-2013

The price that the GAVI Alliance, a public/private partnership, pays for lifesaving pneumococcal vaccines…

GlaxoSmithKlineGlobalPfizerPharmaceuticalPricingVaccines

140 to 164 of 677 results

Back to top